BioVie Inc. Class A Share Price
NASDAQ: BIVI | Micro CapBioVie Inc. Class A Stock Performance
BioVie Inc. Class A Share Price Today
As of 29 October 2026, BioVie Inc. Class A's share price is $1.47. The stock opened at $1.46, compared to its previous close of $1.44. During today's trading session, BioVie Inc. Class A's share price traded between $1.45 and $1.47, with an average price of $1.46. Over the past 52 weeks, the stock has recorded a high of $3.75 and a low of $0.84. In terms of performance, BioVie Inc. Class A's share price has declined by 10.91% over the last six months and is down 16.48% on a year-on-year basis.
BioVie Inc. Class A Share Price Chart
BioVie Inc. Class A Quarterly Profit & Loss
All figures in USD
BioVie Inc. Class A Annual Profit & Loss
All figures in USD
About BioVie Inc. Class A
BioVie Inc is a clinical-stage company developing drug therapies for the treatment of neurological and neurodegenerative disorders and liver disease. Its therapeutic areas include Alzheimer's, Parkinson's, Long COVID, Ascites, Longevity, and Epigenetics. In liver disease, its investigational drug candidate BIV201 (continuous infusion terlipressin) was granted FDA Fast Track status and FDA Orphan Drug designation for ascites due to all etiologies except cancer. BIV201 is being evaluated as a treatment option for patients suffering from life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism.
BioVie Inc. Class A Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.52 | $1.47 | -3.29% |
Sep 2026 | $2.26 | $1.52 | -31.22% |
Aug 2026 | $1.53 | $2.21 | +44.44% |
Jul 2026 | $1.95 | $1.53 | -20.31% |
Jun 2026 | $1.42 | $1.92 | +31.96% |
May 2026 | $1.71 | $1.46 | -11.82% |
Apr 2026 | $1.37 | $1.65 | +17.44% |
Mar 2026 | $1.40 | $1.41 | +0.72% |
Feb 2026 | $1.19 | $1.40 | +22.37% |
Jan 2026 | $1.18 | $1.14 | -1.30% |
Dec 2025 | $1.50 | $1.16 | -18.95% |
Nov 2025 | $1.78 | $1.43 | -19.03% |